# BioNexus Gene Lab Corp: Form 10-K/A for the period ended Dec 31, 2024

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 10-K/A
- Filed: 2025-04-29
- Accepted by EDGAR: Apr 29, 2025, 19:22 ET
- Period: 2024-12-31
- Accession: 0001477932-25-003062
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225003062/bglc_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793225003062/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Shares outstanding | at 2024-12-31 | 17,967,663 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793225003062/bglc_10ka.htm

Filed Apr 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001477932-25-003062. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.